https://www.selleckchem.com/MEK.html
Each year, approximately 8000 cases of cholangiocarcinoma are recorded in the USA. Surgical resection is considered to be the only curative option. Despite surgery as a curative approach, many patients will require adjuvant therapies in the form of chemotherapy (ChT) or chemoradiotherapy (CRT). As such, we sought to analyze outcomes in patients with non-metastatic cholangiocarcinoma receiving adjuvant ChT or CRT following surgical resection. We queried the National Cancer Database (NCD for patients with a diagnosis of non-metastatic cholangiocarci
Gefällt mir
Kommentar
Teilen
